Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2241 (LINC02241)

Target
LINC02241
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

Long intergenic non-protein coding RNA 2241 (LINC02241) is a human long intergenic non-coding RNA (lincRNA) gene. LINC02241 does not code for a protein but has been found to be expressed in various human tissues. Like other lincRNAs, LINC02241 is believed to regulate gene expression through mechanisms such as chromatin remodeling, recruitment of transcription factors, interaction with RNA-binding proteins, and modulation of alternative splicing. Notably, LINC02241 has been associated with cancer, showing expression in hepatocellular carcinoma samples and an association with poor prognosis in colorectal cancer. Recent research suggests LINC02241 may be a source of tumor-specific antigens due to its non-canonical translation into HLA-bound peptides in cancer cells, making it of interest as a potential biomarker and a target for cancer immunotherapy research, despite not being a classic therapeutic target like a receptor, enzyme, or transporter[1][2][3].

Other names
RP11-774D14.105p14.3LINC02241
02

Biological functions

Gene expression regulationChromatin remodelingTranscriptional regulationRNA processingPotential source of tumor-specific antigens
03

Disease associations

Cancer (including associations with hepatocellular carcinoma and poor prognosis in colorectal cancer)Other (potential pan-cancer biomarker)
04

Biomarkers

Associated with poor prognosis in colorectal cancerpan-cancer tumor antigen potential

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2241 (LINC02241).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2241 (LINC02241).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call